Laobaixing Pharmacy Asset Resilience Ratio
Laobaixing Pharmacy asset resilience ratio. Laobaixing Pharmacy (603883) has an Asset Resilience Ratio of 0.01% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 603883 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Laobaixing Pharmacy (2015–2023)
Asset resilience ratio of Laobaixing Pharmacy from 2015 to 2023. This chart shows how Laobaixing Pharmacy's Asset Resilience Ratio has changed over time. Read Laobaixing Pharmacy balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Laobaixing Pharmacy's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 603883 total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.50 Million | 0.01% |
| Total Liquid Assets | CN¥1.50 Million | 0.01% |
Asset Resilience Insights
- Limited Liquidity: Laobaixing Pharmacy maintains only 0.01% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Laobaixing Pharmacy Industry Peers by Asset Resilience Ratio
Compare Laobaixing Pharmacy's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Raia Drogasil S.A
SA:RADL3 |
Pharmaceutical Retailers | 0.46% |
|
Empreendimentos Pague Menos S.A
SA:PGMN3 |
Pharmaceutical Retailers | 0.00% |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3 |
Pharmaceutical Retailers | 2.05% |
|
High Tide Inc
V:HITI |
Pharmaceutical Retailers | 0.02% |
|
Yifeng Pharmacy
SHG:603939 |
Pharmaceutical Retailers | 19.16% |
|
Dashenlin Pharm Grp Co Ltd
SHG:603233 |
Pharmaceutical Retailers | 0.80% |
|
Yunnan Hongxiang Yixintang
SHE:002727 |
Pharmaceutical Retailers | 6.05% |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017 |
Pharmaceutical Retailers | 0.01% |
Laobaixing Pharmacy Asset Resilience Ratio by Year (2015–2023)
Laobaixing Pharmacy asset resilience ratio by year from 2015 to 2023. The table below shows the annual Asset Resilience Ratio data for Laobaixing Pharmacy.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.01% | CN¥1.50 Million ≈ $219.50K |
CN¥21.23 Billion ≈ $3.11 Billion |
-0.01pp |
| 2022-12-31 | 0.01% | CN¥3.00 Million ≈ $438.99K |
CN¥21.40 Billion ≈ $3.13 Billion |
0.00pp |
| 2021-12-31 | 0.02% | CN¥3.00 Million ≈ $438.99K |
CN¥16.96 Billion ≈ $2.48 Billion |
-0.21pp |
| 2020-12-31 | 0.23% | CN¥25.90 Million ≈ $3.79 Million |
CN¥11.28 Billion ≈ $1.65 Billion |
+0.10pp |
| 2019-12-31 | 0.13% | CN¥13.12 Million ≈ $1.92 Million |
CN¥9.92 Billion ≈ $1.45 Billion |
-0.08pp |
| 2018-12-31 | 0.21% | CN¥17.73 Million ≈ $2.60 Million |
CN¥8.48 Billion ≈ $1.24 Billion |
+0.07pp |
| 2017-12-31 | 0.14% | CN¥9.32 Million ≈ $1.36 Million |
CN¥6.70 Billion ≈ $980.26 Million |
+0.07pp |
| 2016-12-31 | 0.07% | CN¥3.49 Million ≈ $510.25K |
CN¥4.91 Billion ≈ $718.44 Million |
-0.02pp |
| 2015-12-31 | 0.09% | CN¥3.58 Million ≈ $524.54K |
CN¥3.80 Billion ≈ $556.14 Million |
-- |
About Laobaixing Pharmacy
LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network. The… Read more